A Member of the University of Maryland Medical System   |   In Partnership with the University of Maryland School of Medicine

Share

Email PageEmail Print PagePrint

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Displasia cervical - Treatment

Nombres alternativos

Cambios precancerosos del cuello uterino; Neoplasia intraepitelial cervical (NIC)

Tratamiento:

El tratamiento depende del grado de la displasia. La displasia leve (LEIBG o NIC I) puede desaparecer en forma espontánea.

  • Lo único que se necesita es una observación cuidadosa con citologías vaginales repetitivas por parte del médico cada 3 a 6 meses.
  • Si los cambios no desaparecen o empeoran, es necesario el tratamiento.

El tratamiento para la displasia de moderada a grave o la displasia leve que no desaparece puede abarcar:

  • Criocirugía para congelar las células anormales.
  • Terapia con láser, la cual usa luz para quemar el tejido anormal.
  • Procedimiento de escisión electroquirúrgica con asa (LEEP, por sus siglas en inglés), el cual utiliza electricidad para eliminar tejido anormal (ver:electrocauterización).
  • Cirugía para extirpar el tejido anormal (conización quirúrgica).

En raras ocasiones, se puede necesitar una histerectomía. Las mujeres a quienes se les trata la displasia necesitan un control constante, generalmente cada 3 a 6 meses o como se los recomiende el médico.

Pronóstico:

Casi todos los casos de displasia cervical se curan con un diagnóstico temprano y un tratamiento oportuno. Algunas veces, la afección reaparece.

Sin tratamiento, la displasia cervical grave puede convertirse en cáncer invasivo. Pueden pasar 10 años o más para que la displasia cervical se convierta en cáncer. El riesgo de cáncer es más bajo para la displasia leve.

Cuándo contactar a un profesional médico:

Solicite una cita con su médico si usted tiene 21 años o más y nunca antes le han hecho un examen pélvico ni una citología vaginal.

Ver: frecuencia del examen físico

  • Reviewed last on: 2/28/2011
  • Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine; Susan Storck, MD, FACOG, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Bellevue, Washington; Clinical Teaching Faculty, Department of Obstetrics and Gynecology, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

Referencias

Cervical cancer in adolescents: screening, evaluation, and manage- ment. Committee Opinion No. 463. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2010;116:469–72.

ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol. 2008;112(6):1419-1444.

Wright TC Jr, Massad LS, Dunton CJ, et al. American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference: 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcihnoma in situ. Am J Obstet Gynecol. 2007;197(4):340-345.

Wright TC Jr, Massad LS, Dunton CJ, et al. American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference: 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197(4):346-355.

Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med. 2009;361:271-278.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
Adam QualityA.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
Connect with UMMC
Facebook Twitter YouTube Blog iPhone

Please rate the quality of this article.

Do you find this article to be helpful / informative?
              
Poor                                       Excellent

Do you have any brief comments on this page: (up to 255 characters)

© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.800.492.5538